Search results
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 6 days agoBenefits For Regenxbio, Solid But most analysts didn't consider Pfizer a serious competitor. "The...
Pfizer Inc. (NYSE:PFE) Shares Sold by CoreFirst Bank & Trust
ETF DAILY NEWS· 1 day agoThe fund owned 42,156 shares of the biopharmaceutical company’s stock after selling 1,011 shares during the period. CoreFirst Bank & Trust’s holdings in Pfizer< ...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 7 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Ables Iannone Moore & Associates Inc. Purchases New Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoAbles Iannone Moore & Associates Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Willner & Heller LLC Purchases New Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoWillner & Heller LLC acquired a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 19,822 shares of the biopharmaceutical ...
Pfizer's gene-therapy trial failure boosts Sarepta's stock
Morningstar· 6 days agoShares of Sarepta Therapeutics Inc. (SRPT) gained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial. Pfizer Inc. said ...
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 2 days agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 6 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 2 days agoPfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. PFE stock was trading ...
Brown Shipley& Co Ltd Has $592,000 Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoBrown Shipley& Co Ltd reduced its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 2.9% during the fourth quarter, according to the company in its most recent ...